中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma

文献类型:期刊论文

作者Zhao, Xiyue1,2,3; Liu, Xiaoyu2,3; Zhang, Pengcheng2,3,4,6; Liu, Yiran2,3,7; Ran, Wei2,3,6; Cai, Ying2,3,6; Wang, Junyang2,3,8; Zhai, Yihui2,3,6; Wang, Guanru2,3; Ding, Yaping1
刊名ACTA PHARMACEUTICA SINICA B
出版日期2019-09-01
卷号9期号:5页码:1050-1060
ISSN号2211-3835
关键词Self-assembly Hydrogel Peptide amphiphile Triptolide Hepatocellular carcinoma
DOI10.1016/j.apsb.2019.06.001
通讯作者Zhang, Pengcheng(pzhang@simm.ac.cn) ; Li, Yaping(ypli@simm.ac.cn)
英文摘要Chemotherapy is among the limited choices approved for the treatment of hepatocellular carcinoma (HCC) at intermediate and advanced stages. Preferential and prolonged drug exposure in diseased sites is required to maximize the therapeutic index of the drug. Here, we report an injectable supramolecular peptide hydrogel as an intraperitoneal depot for localized and sustained release of triptolide for the treatment of orthotopic HCC. We chose peptide amphiphile C-16-GNNQQNYKD-OH-based nanofibers as gelators and carriers for triptolide. Sustained triptolide release from the hydrogel was achieved over 14 days in vitro, with higher accumulation in and cytotoxicity against human HCC Bel-7402 in comparison with L-02 fetal hepatocytes. After intraperitoneal injection, the hydrogel showed prolonged retention over 13 days and preferential accumulation in the liver, realizing HCC growth inhibition by 99.7 +/- 0.1% and animal median survival extension from 19 to 43 days, without causing noticeable pathological changes in the major organs. These results demonstrate that injectable peptide hydrogel can be a potential carrier for localized chemotherapy of HCC. (C) 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
WOS关键词SUPRAMOLECULAR FILAMENT HYDROGELS ; DRUG-DELIVERY ; CANCER-CELLS ; PROTEIN ; DEATH ; NANOFIBERS ; LIPOSOMES ; CARRIERS ; THERAPY
资助项目National Natural Science Foundation of China (China)[81690265] ; National Natural Science Foundation of China (China)[31870995] ; National Natural Science Foundation of China (China)[81671808] ; National Natural Science Foundation of China (China)[81630052] ; Youth Innovation Promotion Association of the Chinese Academy of Sciences (China)[2017335] ; SA-SIBS Scholarship Program (China)
WOS研究方向Pharmacology & Pharmacy
语种英语
出版者INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
WOS记录号WOS:000487282700014
源URL[http://119.78.100.183/handle/2S10ELR8/288508]  
专题新药研究国家重点实验室
通讯作者Zhang, Pengcheng; Li, Yaping
作者单位1.Shanghai Univ, Dept Chem, Shanghai 200444, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
3.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Pharmaceut, Shanghai 201203, Peoples R China
4.Yantai Inst Mat Med, Yantai Key Lab Nanomed & Adv Preparat, Yantai 264000, Peoples R China
5.Yantai Univ, Sch Pharm, Yantai 264005, Peoples R China
6.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
7.Univ Sci & Technol China, Nano Sci & Technol Inst, Suzhou 215123, Peoples R China
8.Jilin Univ, Changchun 130012, Jilin, Peoples R China
推荐引用方式
GB/T 7714
Zhao, Xiyue,Liu, Xiaoyu,Zhang, Pengcheng,et al. Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma[J]. ACTA PHARMACEUTICA SINICA B,2019,9(5):1050-1060.
APA Zhao, Xiyue.,Liu, Xiaoyu.,Zhang, Pengcheng.,Liu, Yiran.,Ran, Wei.,...&Li, Yaping.(2019).Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma.ACTA PHARMACEUTICA SINICA B,9(5),1050-1060.
MLA Zhao, Xiyue,et al."Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma".ACTA PHARMACEUTICA SINICA B 9.5(2019):1050-1060.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。